OBJECTIVE: Individuals with 22q11.2 deletion syndrome are known to be at high risk of developing schizophrenia. Previous imaging studies have provided limited data on the relation of schizophrenia expression in 22q11.2 deletion syndrome to specific regional brain volumetric changes. The authors hypothesized that the main structural brain finding associated with schizophrenia expression in 22q11.2 deletion syndrome, as for schizophrenia in the general population, would be gray matter volumetric deficits, especially in the temporal lobes. METHOD: MR brain images from 29 patients with 22q11.2 deletion syndrome and schizophrenia and 34 comparison subjects with 22q11.2 deletion syndrome and no history of psychosis were analyzed using a voxel-based morphometry method that also yielded volumes for related region-of-interest analyses. The authors compared data from the two groups using an analysis of covariance model correcting for total intracranial volume, age, sex, IQ, and history of congenital cardiac defects. The false discovery rate threshold was set at 0.05 to account for multiple comparisons. RESULTS: Voxel-based morphometry analyses identified significant gray matter reductions in the left superior temporal gyrus (Brodmann's area 22) in the schizophrenia group. There were no significant between-group differences in white matter or CSF volumes. Region-of-interest analyses showed significant bilateral gray matter volume reductions in the temporal lobes and superior temporal gyri in the schizophrenia group. CONCLUSIONS: The structural brain expression of schizophrenia associated with the highly penetrant 22q11.2 deletion involves lower gray matter volumes in temporal lobe regions. These structural MRI findings in a 22q11.2 deletion syndrome form of schizophrenia are consistent with those from studies involving schizophrenia samples from the general population. The results provide further support for 22q11.2 deletion syndrome as a genetic subtype and as a useful neurodevelopmental model of schizophrenia.
OBJECTIVE: Individuals with 22q11.2 deletion syndrome are known to be at high risk of developing schizophrenia. Previous imaging studies have provided limited data on the relation of schizophrenia expression in 22q11.2 deletion syndrome to specific regional brain volumetric changes. The authors hypothesized that the main structural brain finding associated with schizophrenia expression in 22q11.2 deletion syndrome, as for schizophrenia in the general population, would be gray matter volumetric deficits, especially in the temporal lobes. METHOD: MR brain images from 29 patients with 22q11.2 deletion syndrome and schizophrenia and 34 comparison subjects with 22q11.2 deletion syndrome and no history of psychosis were analyzed using a voxel-based morphometry method that also yielded volumes for related region-of-interest analyses. The authors compared data from the two groups using an analysis of covariance model correcting for total intracranial volume, age, sex, IQ, and history of congenital cardiac defects. The false discovery rate threshold was set at 0.05 to account for multiple comparisons. RESULTS: Voxel-based morphometry analyses identified significant gray matter reductions in the left superior temporal gyrus (Brodmann's area 22) in the schizophrenia group. There were no significant between-group differences in white matter or CSF volumes. Region-of-interest analyses showed significant bilateral gray matter volume reductions in the temporal lobes and superior temporal gyri in the schizophrenia group. CONCLUSIONS: The structural brain expression of schizophrenia associated with the highly penetrant 22q11.2 deletion involves lower gray matter volumes in temporal lobe regions. These structural MRI findings in a 22q11.2 deletion syndrome form of schizophrenia are consistent with those from studies involving schizophrenia samples from the general population. The results provide further support for 22q11.2 deletion syndrome as a genetic subtype and as a useful neurodevelopmental model of schizophrenia.
Authors: Jae Jin Kim; Benedicto Crespo-Facorro; Nancy C Andreasen; Daniel S O'Leary; Vincent Magnotta; Peg Nopoulos Journal: Schizophr Res Date: 2003-04-01 Impact factor: 4.939
Authors: D M McDonald-McGinn; R Kirschner; E Goldmuntz; K Sullivan; P Eicher; M Gerdes; E Moss; C Solot; P Wang; I Jacobs; S Handler; C Knightly; K Heher; M Wilson; J E Ming; K Grace; D Driscoll; P Pasquariello; P Randall; D Larossa; B S Emanuel; E H Zackai Journal: Genet Couns Date: 1999
Authors: M S Keshavan; G L Haas; C E Kahn; E Aguilar; E L Dick; N R Schooler; J A Sweeney; J W Pettegrew Journal: J Psychiatr Res Date: 1998 May-Aug Impact factor: 4.791
Authors: Alex Sumich; Xavier A Chitnis; Dominic G Fannon; Séamus O'Ceallaigh; Victor C Doku; Abi Falrowicz; Nicolette Marshall; Vallakalil M Matthew; Mark Potter; Tonmoy Sharma Journal: Am J Psychiatry Date: 2002-07 Impact factor: 18.112
Authors: Anne S Bassett; Eva W C Chow; Philip AbdelMalik; Mirona Gheorghiu; Janice Husted; Rosanna Weksberg Journal: Am J Psychiatry Date: 2003-09 Impact factor: 18.112
Authors: J Eric Schmitt; Simon Vandekar; James Yi; Monica E Calkins; Kosha Ruparel; David R Roalf; Daneen Whinna; Margaret C Souders; Theodore D Satterwaite; Karthik Prabhakaran; Donna M McDonald-McGinn; Elaine H Zackai; Ruben C Gur; Beverly S Emanuel; Raquel E Gur Journal: Biol Psychiatry Date: 2014-11-21 Impact factor: 13.382
Authors: Lucia-Manuela Cantonas; Valentina Mancini; Tonia A Rihs; Vincent Rochas; Maude Schneider; Stephan Eliez; Christoph M Michel Journal: Schizophr Bull Date: 2021-01-23 Impact factor: 9.306
Authors: Shabnam Peyvandi; Philip J Lupo; Jennifer Garbarini; Stacy Woyciechowski; Sharon Edman; Beverly S Emanuel; Laura E Mitchell; Elizabeth Goldmuntz Journal: Pediatr Cardiol Date: 2013-04-21 Impact factor: 1.655
Authors: Julio Villalon-Reina; Neda Jahanshad; Elliott Beaton; Arthur W Toga; Paul M Thompson; Tony J Simon Journal: Neuroimage Date: 2013-04-18 Impact factor: 6.556
Authors: Maria Jalbrzikowski; Chelsea Carter; Damla Senturk; Carolyn Chow; Jessica M Hopkins; Michael F Green; Adriana Galván; Tyrone D Cannon; Carrie E Bearden Journal: Schizophr Res Date: 2012-10-31 Impact factor: 4.939